Evaluation of Mesenchymal Stem Cell transplantation (MSCS) in the treatment of Erectile Dysfunction (ED)

Not Applicable

Recruiting

• Conditions: Erectile Dysfunction.; N52.9; Male erectile dysfunction, unspecified

• Registration Number: IRCT20190624043991N11
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

Mental Health
Do not take psychiatric drugs
Age range 18-70 years
No possibility of damage to the main pelvic arteries
Reluctance to change the penis prosthesis
Tendency to perform stem cell injection therapy

Exclusion Criteria

Patients with Cardiovascular disease
Underlying diseases
Psychiatric problems or Addiction
Failure to follow the patient at the appointed times
Deactivation of Sexual Life
Neurologic or Hormonal Erectile Dysfunction
Lack of Sexual Interest

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improve erectile quality. Timepoint: One month, two months, three months, six months and one year after adipose derived mesenchymal stem cells injection. Method of measurement: Record of Peak systolic velocity (PSV) and end diastolic velocity (EDV) and complete the International Index of Erectile Function (IIEF-5) questionnaire and perform color Doppler.